Ashley Plant - Fox, MD


Dr. Ashley S. Plant-Fox is a Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine and attending neuro-oncologist at Ann & Robert H. Lurie Children’s Hospital. Dr. Plant-Fox completed her medical degree at Stanford University School of Medicine and pediatrics training at University of California, Los Angeles. She went on to complete her pediatric hematology/oncology fellowship training and additional training in neuro-oncology at Dana Farber Cancer Institute/Boston Children’s Hospital. Dr. Plant-Fox’s research is focused on immunophenotyping of pediatric brain tumors and early phase clinical trials for immunotherapy in malignant brain tumors. Dr. Plant-Fox is currently the lead Principal Investigator for a multi-center, phase I, open-label, plus expansion clinical trial for rHSC-DIPGVax in combination with Balstilimab and Zalifrelimab for diffuse intrinsic pontine glioma/diffuse midline glioma. rHSC-DIPGVax is an off-the-shelf neo-antigen heat shock protein vaccine containing 16 peptides reflecting neo-epitopes found in the majority of DIPG and DMG tumors. Dr. Plant-Fox is the endowed A.M. Khokhar Research Scholar and Will Irwin Research Scholar. Her work is funded by the Will Irwin Fund through the Pediatric Cancer Research Foundation, the Team Jack Foundation, the RDL Foundation, the Elerding Foundation, the LiamBear Strong Foundation, the Shaw Foundation, and the Ross K. MacNeill Foundation.

To be evaluated for the DIPG DMG National Brain Tumor Board, please complete the following information. Our coordinator will contact the patient provider within three business days of submittal.